HEMOCHROMATOSIS SCREENING IN ASYMPTOMATIC AMBULATORY MEN 30 YEARS OF AGE AND OLDER

被引:89
作者
BAER, DM [1 ]
SIMONS, JL [1 ]
STAPLES, RL [1 ]
RUMORE, GJ [1 ]
MORTON, CJ [1 ]
机构
[1] KAISER PERMANENTE MED CTR,DEPT PATHOL,OAKLAND,CA 94611
关键词
D O I
10.1016/S0002-9343(99)80346-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: TO perform a cost-benefit analysis of screening for hereditary hemochromatosis. PATIENTS AND METHODS: A total of 3,977 consecutive men greater than or equal to 30 years of age who presented for routine health checkups at a HEALTH maintenance organization medical center were screened for hereditary hemochromatosis by measuring transferrin saturation. Subjects with repeated transferrin saturation greater than or equal to 62% and ferritin level greater than or equal to 500 ng/mL (greater than or equal to 500 mu g/L) were referred for liver biopsy. Subjects with transferrin saturation <15% were referred for evaluation. Laboratory testing, screening, and abnormal screening test evaluation procedures were identified by chart review. RESULTS: Forty patients had transferrin saturation greater than or equal to 62%. One hundred seventy-two had transferrin saturation <15%. Eight patients with hemochromatosis were identified. The 3 patients most seriously affected had hepatic iron concentrations >250 mu mol/g dry weight. Two of them had hepatic fibrosis. Seven cases of hemochromatosis were found among 1,974 white subjects who were screened. Only 1 case was found among the remaining subjects. CONCLUSIONS: Our observations support routine screening with transferrin saturation for white men greater than or equal to 30 years of age.
引用
收藏
页码:464 / 468
页数:5
相关论文
共 29 条
[1]  
Adams P C, 1989, Adv Intern Med, V34, P111
[2]   LONG-TERM SURVIVAL ANALYSIS IN HEREDITARY HEMOCHROMATOSIS [J].
ADAMS, PC ;
SPEECHLEY, M ;
KERTESZ, AE .
GASTROENTEROLOGY, 1991, 101 (02) :368-372
[3]   VALUE OF HEPATIC IRON MEASUREMENTS IN EARLY HEMOCHROMATOSIS AND DETERMINATION OF THE CRITICAL IRON LEVEL ASSOCIATED WITH FIBROSIS [J].
BASSETT, ML ;
HALLIDAY, JW ;
POWELL, LW .
HEPATOLOGY, 1986, 6 (01) :24-29
[4]  
BORWEIN ST, 1983, CLIN INVEST MED, V6, P171
[5]   HEMOCHROMATOSIS - CURRENT CONCEPTS AND MANAGEMENT [J].
CROSBY, WH .
HOSPITAL PRACTICE, 1987, 22 (02) :173-&
[6]   LIVER PATHOLOGY IN GENETIC HEMOCHROMATOSIS - A REVIEW OF 135 HOMOZYGOUS CASES AND THEIR BIOCLINICAL CORRELATIONS [J].
DEUGNIER, YM ;
LOREAL, O ;
TURLIN, B ;
GUYADER, D ;
JOUANOLLE, H ;
MOIRAND, R ;
JACQUELINET, C ;
BRISSOT, P .
GASTROENTEROLOGY, 1992, 102 (06) :2050-2059
[7]  
EDWARDS CQ, 1993, NEW ENGL J MED, V328, P1616
[8]   PREVALENCE OF HEMOCHROMATOSIS AMONG 11,065 PRESUMABLY HEALTHY BLOOD-DONORS [J].
EDWARDS, CQ ;
GRIFFEN, LM ;
GOLDGAR, D ;
DRUMMOND, C ;
SKOLNICK, MH ;
KUSHNER, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (21) :1355-1362
[9]  
FAIRBANKS VF, 1991, HOSP PRACT, V26, P17
[10]   SURVIVAL AND PROGNOSTIC FACTORS IN 212 ITALIAN PATIENTS WITH GENETIC HEMOCHROMATOSIS [J].
FARGION, S ;
MANDELLI, C ;
PIPERNO, A ;
CESANA, B ;
FRACANZANI, AL ;
FRAQUELLI, M ;
BIANCHI, PA ;
FIORELLI, G ;
CONTE, D .
HEPATOLOGY, 1992, 15 (04) :655-659